日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting

具有可诱导Caspase-9自杀基因的嵌合抗原受体T细胞通过靶向B7-H3根除葡萄膜黑色素瘤肝转移

Marco Ventin # ,Giulia Cattaneo # ,Shahrzad Arya ,Jingyu Jia ,Maria C Gelmi ,Yi Sun ,Luke Maggs ,Bruce R Ksander ,Robert M Verdijk ,Genevieve M Boland ,Russell W Jenkins ,Rizwan Haq ,Martine J Jager ,Xinhui Wang ,Sandra Ryeom ,Cristina R Ferrone

Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models

在黑色素瘤侧腹和脑转移模型中,抗PD-1+LAG-3和抗PD-1+CTLA-4联合疗法的疗效对CD4+ T细胞的需求存在差异

Manali S Phadke ,Jiannong Li ,Zhihua Chen ,Paulo C Rodriguez ,Jessica K Mandula ,Lilit Karapetyan ,Peter A Forsyth ,Y Ann Chen ,Keiran S M Smalley

LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma

LAG3(LAG-3,CD223)DNA甲基化与肿瘤细胞和免疫细胞的LAG3表达、免疫细胞浸润以及透明细胞肾细胞癌的总体生存率相关。

Klümper, Niklas; Ralser, Damian J; Bawden, Emma Grace; Landsberg, Jenny; Zarbl, Romina; Kristiansen, Glen; Toma, Marieta; Ritter, Manuel; Hölzel, Michael; Ellinger, Jörg; Dietrich, Dimo

LAG3 (CD223) as a cancer immunotherapy target

LAG3 (CD223) 作为癌症免疫治疗靶点

Andrews, Lawrence P; Marciscano, Ariel E; Drake, Charles G; Vignali, Dario A A

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity

浆细胞样树突状细胞(pDCs)中的淋巴细胞活化基因-3(LAG-3,CD223):恢复活性抗肿瘤免疫的分子靶点

Castelli, Chiara; Triebel, Frédéric; Rivoltini, Licia; Camisaschi, Chiara